Literature DB >> 22315229

HEAT repeat 1 motif is required for B56γ-containing protein phosphatase 2A (B56γ-PP2A) holoenzyme assembly and tumor-suppressive function.

Yumiko Nobumori1, Geoffrey P Shouse, Li Fan, Xuan Liu.   

Abstract

Protein phosphatase 2A (PP2A) enzyme consists of a heterodimeric core (AC core) comprising a scaffolding subunit (A), a catalytic subunit (C), and a variable regulatory subunit (B). Earlier studies suggest that upon DNA damage, a specific B subunit, B56γ, bridges the PP2A AC core to p53, leading to dephosphorylation of p53 at Thr-55, induction of the p53 transcriptional target p21, and the inhibition of cell proliferation and transformation. In addition to dephosphorylation of p53, B56γ-PP2A also inhibits cell proliferation and transformation by an unknown mechanism. B56γ contains 18 α-helices that are organized into eight HEAT (Huntington-elongation-A subunit-TOR) repeat motifs. Although previous crystal structure study has revealed the residues of B56γ that directly contact the A and C subunits, the contribution of HEAT repeats to holoenzyme assembly and to B56γ-PP2A tumor-suppressive function remains to be elucidated. Here, we show that HEAT repeat 1 is required for the interaction of B56γ with the PP2A AC core and, more importantly, for B56γ-PP2A tumor-suppressive function. Within this region, we identified a tumor-associated mutation, C39R, which disrupts the interaction of B56γ with the AC core and thus was unable to mediate dephosphorylation of p53 by PP2A. Furthermore, due to its lack of AC interaction, C39R was also unable to promote the p53-independent tumor-suppressive function of B56γ-PP2A. This study provides structural insight into the PP2A holoenzyme assembly and emphasizes the importance of HEAT repeat 1 in B56γ-PP2A tumor-suppressive function.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22315229      PMCID: PMC3322884          DOI: 10.1074/jbc.M111.334094

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  20 in total

1.  A signalling pathway controlling c-Myc degradation that impacts oncogenic transformation of human cells.

Authors:  Elizabeth Yeh; Melissa Cunningham; Hugh Arnold; Dawn Chasse; Teresa Monteith; Giovanni Ivaldi; William C Hahn; P Todd Stukenberg; Shirish Shenolikar; Takafumi Uchida; Christopher M Counter; Joseph R Nevins; Anthony R Means; Rosalie Sears
Journal:  Nat Cell Biol       Date:  2004-03-14       Impact factor: 28.824

2.  Identification of specific PP2A complexes involved in human cell transformation.

Authors:  Wen Chen; Richard Possemato; K Thirza Campbell; Courtney A Plattner; David C Pallas; William C Hahn
Journal:  Cancer Cell       Date:  2004-02       Impact factor: 31.743

3.  Role for the PP2A/B56delta phosphatase in regulating 14-3-3 release from Cdc25 to control mitosis.

Authors:  Seth S Margolis; Jennifer A Perry; Craig M Forester; Leta K Nutt; Yanxiang Guo; Melanie J Jardim; Michael J Thomenius; Christopher D Freel; Rashid Darbandi; Jung-Hyuck Ahn; Jason D Arroyo; Xiao-Fan Wang; Shirish Shenolikar; Angus C Nairn; William G Dunphy; William C Hahn; David M Virshup; Sally Kornbluth
Journal:  Cell       Date:  2006-11-17       Impact factor: 41.582

4.  Disruption of protein phosphatase 2A subunit interaction in human cancers with mutations in the A alpha subunit gene.

Authors:  R Ruediger; H T Pham; G Walter
Journal:  Oncogene       Date:  2001-01-04       Impact factor: 9.867

5.  High complexity in the expression of the B' subunit of protein phosphatase 2A0. Evidence for the existence of at least seven novel isoforms.

Authors:  C Csortos; S Zolnierowicz; E Bakó; S D Durbin; A A DePaoli-Roach
Journal:  J Biol Chem       Date:  1996-02-02       Impact factor: 5.157

6.  Cancer-associated PP2A Aalpha subunits induce functional haploinsufficiency and tumorigenicity.

Authors:  Wen Chen; Jason D Arroyo; Jamie C Timmons; Richard Possemato; William C Hahn
Journal:  Cancer Res       Date:  2005-09-15       Impact factor: 12.701

7.  B56-containing PP2A dephosphorylate ERK and their activity is controlled by the early gene IEX-1 and ERK.

Authors:  Claire Letourneux; Géraldine Rocher; Françoise Porteu
Journal:  EMBO J       Date:  2006-02-02       Impact factor: 11.598

8.  Frequent mutations of chromatin remodeling gene ARID1A in ovarian clear cell carcinoma.

Authors:  Siân Jones; Tian-Li Wang; Ie-Ming Shih; Tsui-Lien Mao; Kentaro Nakayama; Richard Roden; Ruth Glas; Dennis Slamon; Luis A Diaz; Bert Vogelstein; Kenneth W Kinzler; Victor E Velculescu; Nickolas Papadopoulos
Journal:  Science       Date:  2010-09-08       Impact factor: 47.728

9.  Assignment of human protein phosphatase 2A regulatory subunit genes b56alpha, b56beta, b56gamma, b56delta, and b56epsilon (PPP2R5A-PPP2R5E), highly expressed in muscle and brain, to chromosome regions 1q41, 11q12, 3p21, 6p21.1, and 7p11.2 --> p12.

Authors:  B McCright; A R Brothman; D M Virshup
Journal:  Genomics       Date:  1996-08-15       Impact factor: 5.736

10.  Protein phosphatase 2A regulatory subunit B56alpha associates with c-myc and negatively regulates c-myc accumulation.

Authors:  Hugh K Arnold; Rosalie C Sears
Journal:  Mol Cell Biol       Date:  2006-04       Impact factor: 4.272

View more
  6 in total

1.  Leucine-rich repeat-containing protein 59 mediates nuclear import of cancerous inhibitor of PP2A in prostate cancer cells.

Authors:  Rajash Pallai; Aishwarya Bhaskar; Natalie Barnett-Bernodat; Christina Gallo-Ebert; Michelle Pusey; Joseph T Nickels; Lyndi M Rice
Journal:  Tumour Biol       Date:  2015-04-02

2.  B56γ tumor-associated mutations provide new mechanisms for B56γ-PP2A tumor suppressor activity.

Authors:  Yumiko Nobumori; Geoffrey P Shouse; Yong Wu; Kyu Joon Lee; Binghui Shen; Xuan Liu
Journal:  Mol Cancer Res       Date:  2013-05-30       Impact factor: 5.852

3.  Selective inhibitors of nuclear export (SINE) in hematological malignancies.

Authors:  Arundhati Das; Guoqing Wei; Kaushal Parikh; Delong Liu
Journal:  Exp Hematol Oncol       Date:  2015-03-01

Review 4.  The broken "Off" switch in cancer signaling: PP2A as a regulator of tumorigenesis, drug resistance, and immune surveillance.

Authors:  Peter P Ruvolo
Journal:  BBA Clin       Date:  2016-08-03

Review 5.  Protein phosphatase 2A - structure, function and role in neurodevelopmental disorders.

Authors:  Priyanka Sandal; Chian Ju Jong; Ronald A Merrill; Jianing Song; Stefan Strack
Journal:  J Cell Sci       Date:  2021-07-06       Impact factor: 5.235

Review 6.  Protein phosphatases in the regulation of mitosis.

Authors:  Jakob Nilsson
Journal:  J Cell Biol       Date:  2018-11-16       Impact factor: 10.539

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.